John A. Howe

2.9k total citations
52 papers, 2.0k citations indexed

About

John A. Howe is a scholar working on Infectious Diseases, Molecular Biology and Genetics. According to data from OpenAlex, John A. Howe has authored 52 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 19 papers in Molecular Biology and 18 papers in Genetics. Recurrent topics in John A. Howe's work include HIV/AIDS drug development and treatment (15 papers), Virus-based gene therapy research (14 papers) and Hepatitis C virus research (11 papers). John A. Howe is often cited by papers focused on HIV/AIDS drug development and treatment (15 papers), Virus-based gene therapy research (14 papers) and Hepatitis C virus research (11 papers). John A. Howe collaborates with scholars based in United States, Canada and United Kingdom. John A. Howe's co-authors include Stanley T. Bayley, Philip E. Branton, Cay Egan, Tony N. Jelsma, John W. Newport, S. T. Bayley, Joe S. Mymryk, B Ferguson, Michael Howell and Tim Hunt and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Genes & Development and Nature Biotechnology.

In The Last Decade

John A. Howe

52 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John A. Howe United States 24 1.2k 918 574 344 328 52 2.0k
Christine L. White United States 24 722 0.6× 691 0.8× 455 0.8× 381 1.1× 349 1.1× 46 1.9k
Patrick Arbuthnot South Africa 34 2.5k 2.1× 644 0.7× 330 0.6× 606 1.8× 1.6k 4.8× 128 3.7k
Orgad Laub Israel 24 812 0.7× 329 0.4× 265 0.5× 408 1.2× 1.3k 3.9× 40 2.2k
S Oroszlan United States 19 941 0.8× 322 0.4× 225 0.4× 348 1.0× 257 0.8× 28 2.0k
Beihua Dong United States 24 1.6k 1.3× 322 0.4× 359 0.6× 488 1.4× 398 1.2× 43 2.9k
Richard Harrop United Kingdom 29 660 0.6× 436 0.5× 1.0k 1.8× 104 0.3× 266 0.8× 66 2.5k
Ronald Ellis United States 20 1.6k 1.4× 849 0.9× 582 1.0× 118 0.3× 236 0.7× 46 2.6k
Sabrina Schreiner Germany 22 876 0.7× 674 0.7× 313 0.5× 112 0.3× 387 1.2× 54 1.4k
S D Showalter United States 21 789 0.7× 323 0.4× 249 0.4× 185 0.5× 655 2.0× 45 1.9k
Nava Sarver United States 23 1.4k 1.2× 653 0.7× 200 0.3× 427 1.2× 399 1.2× 39 2.3k

Countries citing papers authored by John A. Howe

Since Specialization
Citations

This map shows the geographic impact of John A. Howe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Howe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Howe more than expected).

Fields of papers citing papers by John A. Howe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Howe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Howe. The network helps show where John A. Howe may publish in the future.

Co-authorship network of co-authors of John A. Howe

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Howe. A scholar is included among the top collaborators of John A. Howe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Howe. John A. Howe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Citron, Michael, Meng Shi, William Rose, et al.. (2024). Evaluation of a non-nucleoside inhibitor of the RSV RNA-dependent RNA polymerase in translatable animals models. Journal of Infection. 89(6). 106325–106325. 1 indexed citations
2.
Strizki, Julie, John M. Gaspar, John A. Howe, et al.. (2023). Molnupiravir maintains antiviral activity against SARS-CoV-2 variants and exhibits a high barrier to the development of resistance. Antimicrobial Agents and Chemotherapy. 68(1). e0095323–e0095323. 16 indexed citations
3.
Meyer, Brian K., Debbie Nahas, Andrew Danziger, et al.. (2023). Evaluation of luciferase and prefusion-stabilized F protein from respiratory syncytial virus mRNA/LNPs in pre-clinical models using jet delivery compared to needle and syringe. Vaccine X. 16. 100420–100420. 3 indexed citations
4.
Rizvi, Noreen F., John A. Howe, Ali Nahvi, et al.. (2018). Discovery of Selective RNA-Binding Small Molecules by Affinity-Selection Mass Spectrometry. ACS Chemical Biology. 13(3). 820–831. 81 indexed citations
5.
Wang, Hao, Paul A. Mann, Li Xiao, et al.. (2017). Dual-Targeting Small-Molecule Inhibitors of the Staphylococcus aureus FMN Riboswitch Disrupt Riboflavin Homeostasis in an Infectious Setting. Cell chemical biology. 24(5). 576–588.e6. 72 indexed citations
6.
Barnard, Richard J. O., John A. Howe, Robert A. Ogert, et al.. (2013). Analysis of boceprevir resistance associated amino acid variants (RAVs) in two phase 3 boceprevir clinical studies. Virology. 444(1-2). 329–336. 54 indexed citations
7.
8.
Brass, Clifford A., Richard J. O. Barnard, John A. Howe, et al.. (2011). 1194 SUSTAINED VIROLOGIC RESPONSE AND BOCEPREVIR RESISTANCE-ASSOCIATED VARIANTS OBSERVED IN PATIENTS INFECTED WITH HCV GENOTPYPE 1A/1B WHEN TREATED WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN. Journal of Hepatology. 54. S471–S472. 9 indexed citations
9.
Ogert, Robert A., Lei Ba, Yan Hou, et al.. (2009). Structure-Function Analysis of Human Immunodeficiency Virus Type 1 gp120 Amino Acid Mutations Associated with Resistance to the CCR5 Coreceptor Antagonist Vicriviroc. Journal of Virology. 83(23). 12151–12163. 31 indexed citations
10.
Buontempo, Peter, Lisa Wojcik, Robert A. Ogert, et al.. (2009). Quantifying the relationship between HIV-1 susceptibility to CCR5 antagonists and virus affinity for antagonist-occupied co-receptor. Virology. 395(2). 268–279. 4 indexed citations
11.
12.
Hou, Yan, Andrew Prongay, Boris Feld, et al.. (2008). Screening for Antiviral Inhibitors of the HIV Integrase–LEDGF/p75 Interaction Using the AlphaScreen™ Luminescent Proximity Assay. SLAS DISCOVERY. 13(5). 406–414. 40 indexed citations
13.
14.
Ahmed, C. M. Iqbal, Ken N. Wills, Barry J. Sugarman, et al.. (2001). Selective Expression of Nonsecreted Interferon by an Adenoviral Vector Confers Antiproliferative and Antiviral Properties and Causes Reduction of Tumor Growth in Nude Mice. Journal of Interferon & Cytokine Research. 21(6). 399–408. 27 indexed citations
15.
Ahmed, C. M. Iqbal, Duane E. Johnson, G W Demers, et al.. (2001). Interferon α2b gene delivery using adenoviral vector causes inhibition of tumor growth in xenograft models from a variety of cancers. Cancer Gene Therapy. 8(10). 788–795. 33 indexed citations
16.
17.
18.
Howe, John A.. (1979). Pleistocene Equidae from Sheridan County, Nebraska. Journal of Paleontology. 53(5). 1228–1236. 3 indexed citations
19.
Howe, John A.. (1970). The range of variation in Equus (Plesippus) simplicidens Cope from the Broadwater quarries of Nebraska. Journal of Paleontology. 44(5). 958–968. 8 indexed citations
20.
Howe, John A.. (1966). The Oligocene rodent Ischyromys in Nebraska. Journal of Paleontology. 40(5). 1200–1210. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christine L. White Breakdown of academic impact, for papers by Patrick Arbuthnot Breakdown of academic impact, for papers by Orgad Laub Breakdown of academic impact, for papers by S Oroszlan Breakdown of academic impact, for papers by Beihua Dong Breakdown of academic impact, for papers by Richard Harrop Breakdown of academic impact, for papers by Ronald Ellis Breakdown of academic impact, for papers by Sabrina Schreiner Breakdown of academic impact, for papers by S D Showalter Breakdown of academic impact, for papers by Nava Sarver
Rankless by CCL
2026